Late Breaking Abstract - Activation of a murine skeletal muscle M3 muscarinic Designer Receptor Exclusively Activated by Designer Drug (DREADD) has cardiopulmonary consequences

S. Vincent (Kingston, Canada), D. Bone (Bethesda, United States of America), J. Wess (Bethesda, United States of America), J. Fisher (Kingston, Canada)

Source: International Congress 2019 – Advances in COPD pharmacology
Session: Advances in COPD pharmacology
Session type: Poster Discussion
Number: 2028
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Vincent (Kingston, Canada), D. Bone (Bethesda, United States of America), J. Wess (Bethesda, United States of America), J. Fisher (Kingston, Canada). Late Breaking Abstract - Activation of a murine skeletal muscle M3 muscarinic Designer Receptor Exclusively Activated by Designer Drug (DREADD) has cardiopulmonary consequences. 2028

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



Late Breaking Abstract - Transient Receptor Potential Vanilloid subtype 4 in patients with lung cancer
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020




The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha
Source: International Congress 2018 – Basic pharmacology
Year: 2018

TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Late Breaking Abstract - Chronic Hypoxia Promotes Pulmonary Venous Smooth Muscle Cells Proliferation by Upregulating Calcium Sensing Receptor
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018

Effects of Inhaled Long Acting Muscarinic Antagonist (LAMA) on Lung Functions in Adult Stable Bronchiectasis
Source: International Congress 2018 – COPD management
Year: 2018


Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017


Late Breaking Abstract - Endothelial Cell-Specific Anticoagulation Reduces Inflammation in a Mouse Model of ALI
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017

Modulation of Transient Receptor Potential Vanilloid-1 (TRPV1) response by inhaled prostaglandin-E2 and bradykinin
Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction
Year: 2018



LSC - 2017 - Proteasomal Activator 200 (PA200) Regulates Cellular Proliferation: A Putative Role For IPF And Lung Cancer Pathogenesis
Source: International Congress 2017 – New insights into pathogenesis of lung disease 
Year: 2017

Distal Lung Epithelial Regeneration is Driven by Notch Pathway Inhibition and Enhanced by Ex Vivo Native Lung Scaffold Biomimetic Culture
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019



Loss of the calcium-sensing receptor (CaSR) decreases slowly-adapting receptor responsiveness to mechanical stretch independent of oxygenation status
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

RAGE Partially Mediates Cigarettes Smoke Extract induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


Late Breaking Abstract - Two Phase 3 Randomized Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist, in Refractory or Unexplained Chronic Cough (COUGH-1 and COUGH-2)
Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis
Year: 2020




Immunity-6® Inhibits BEAS-2B and MRC-5 Cells Activation Induced by Sars-COV-2: Involvement with Purinergic Signaling
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021

Comparative Efficacy of Long-Acting Muscarinic Antagonists in COPD: Real Life Study
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020


Exosomes from Intermittent Hypoxia Treated Lung Adenocarcinoma Cell Line Up-regulate Programmed Death Ligand 1 Expression through HIF-1a Pathway in Macrophages
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020


Development of Highly Organized Human Leukocyte Infiltration Patterns and Human Lymphoid Tissue in Lungs of Humanized Immune System (HIS) Mice
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019

Muscarinic M3 receptors on structural cells regulate neutrophilic inflammation in mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014